Advancement and prospects of tumor gene therapy
- PMID: 21352695
- PMCID: PMC4013314
- DOI: 10.5732/cjc.010.10074
Advancement and prospects of tumor gene therapy
Abstract
Gene therapy is one of the most attractive fields in tumor therapy. In past decades, significant progress has been achieved. Various approaches, such as viral and non-viral vectors and physical methods, have been developed to make gene delivery safer and more efficient. Several therapeutic strategies have evolved, including gene-based (tumor suppressor genes, suicide genes, antiangiogenic genes, cytokine and oxidative stress-based genes) and RNA-based (antisense oligonucleotides and RNA interference) approaches. In addition, immune response-based strategies (dendritic cell- and T cell-based therapy) are also under investigation in tumor gene therapy. This review highlights the progress and recent developments in gene delivery systems, therapeutic strategies, and possible clinical directions for gene therapy.
Similar articles
-
Suicide gene therapy in cancer: where do we stand now?Cancer Lett. 2012 Nov 28;324(2):160-70. doi: 10.1016/j.canlet.2012.05.023. Epub 2012 May 24. Cancer Lett. 2012. PMID: 22634584 Review.
-
Non-viral delivery of RNA interference targeting cancer cells in cancer gene therapy.Curr Gene Ther. 2012 Aug;12(4):275-84. doi: 10.2174/156652312802083576. Curr Gene Ther. 2012. PMID: 22856602 Review.
-
Viral-mediated gene transfer for cancer treatment.Curr Pharm Biotechnol. 2002 Jun;3(2):151-64. doi: 10.2174/1389201023378445. Curr Pharm Biotechnol. 2002. PMID: 12022258 Review.
-
Vector-mediated cancer gene therapy: an overview.Cancer Biol Ther. 2005 May;4(5):512-7. doi: 10.4161/cbt.4.5.1705. Epub 2005 May 5. Cancer Biol Ther. 2005. PMID: 15908802 Review.
-
Cancer suicide gene therapy: a patent review.Expert Opin Ther Pat. 2016 Sep;26(9):1095-104. doi: 10.1080/13543776.2016.1211640. Epub 2016 Jul 20. Expert Opin Ther Pat. 2016. PMID: 27424657 Review.
Cited by
-
Tumor progression-dependent angiogenesis in gastric cancer and its potential application.World J Gastrointest Oncol. 2019 Sep 15;11(9):686-704. doi: 10.4251/wjgo.v11.i9.686. World J Gastrointest Oncol. 2019. PMID: 31558974 Free PMC article. Review.
-
Activin A expression in esophageal carcinoma and its association with tumor aggressiveness and differentiation.Oncol Lett. 2015 Jul;10(1):143-148. doi: 10.3892/ol.2015.3248. Epub 2015 May 20. Oncol Lett. 2015. PMID: 26170990 Free PMC article.
-
Tumor angiogenesis and anti-angiogenic gene therapy for cancer.Oncol Lett. 2018 Jul;16(1):687-702. doi: 10.3892/ol.2018.8733. Epub 2018 May 17. Oncol Lett. 2018. PMID: 29963134 Free PMC article. Review.
-
Ferroptosis-Inducing Nanomedicine for Cancer Therapy.Front Pharmacol. 2021 Dec 20;12:735965. doi: 10.3389/fphar.2021.735965. eCollection 2021. Front Pharmacol. 2021. PMID: 34987385 Free PMC article. Review.
-
Effect of IL-17 in the development of colon cancer in mice.Oncol Lett. 2016 Dec;12(6):4929-4936. doi: 10.3892/ol.2016.5329. Epub 2016 Oct 31. Oncol Lett. 2016. PMID: 28101230 Free PMC article.
References
-
- Blaese RM, Culver KW, Miller AD, et al. T lymphocyte–directed gene therapy for ADA-SCID: initial trial results after 4 years [J] Science. 1995;270(5235):475–480. - PubMed
-
- Edelstein ML, Abedi MR, Wixon J, et al. Gene therapy clinical trials worldwide 1989-2004-an overview [J] J Gene Med. 2004;6(6):597–602. - PubMed
-
- Cotrim AP, Baum BJ. Gene therapy: some history, applications, problems, and prospects [J] Toxicol Pathology. 2008;36(1):97–103. - PubMed
-
- El-Aneed A. An overview of current delivery systems in cancer gene therapy [J] J Control Release. 2004;94(1):1–14. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous